WallStreetZenWallStreetZen

NASDAQ: ACHV
Achieve Life Sciences Inc Stock Ownership - Who owns Achieve Life Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Achieve Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard Alistair StewartChief Executive Officer2025-09-18129,501$2.92
$378.14kSell
Mark K. OkiChief Financial Officer2025-09-1850,060$2.92
$146.18kSell
Cindy JacobsPresident CMO2025-09-0427,629$2.77
$76.53kSell
Thomas Braxton KingDirector2025-09-04139,858$2.77
$387.41kSell
Jerry WanPrincipal Accounting Officer2025-09-0414,070$2.77
$38.97kSell
Jaime XinosChief Commercial Officer2025-09-0420,854$2.77
$57.77kSell
Richard Alistair StewartChieve Executive Officer2025-03-1710,000$2.86
$28.60kBuy
Mark K. OkiChief Financial Officer2025-03-1710,000$2.89
$28.89kBuy

1 of 1

ACHV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACHV insiders and whales buy or sell their stock.

ACHV Shareholders

What type of owners hold Achieve Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Propel Bio Management LLC7.11%3,786,425$17.57MInstitution
Dialectic Capital Management LP6.67%3,549,000$16.47MInsider
Vanguard Group Inc4.62%2,461,802$11.42MInstitution
Robert Schacter3.43%1,827,426$8.48MInsider
Armistice Capital LLC2.99%1,593,188$7.39MInsider
Simplify Asset Management Inc2.23%1,184,512$5.50MInstitution
Ventures West Capital Ltd1.82%968,582$4.49MInsider
Marshall Wace LLP1.46%774,853$3.60MInstitution
Nantahala Capital Management LLC1.22%648,885$3.01MInstitution
Hig Oncogenex Inc1.02%545,512$2.53MInsider

1 of 3

ACHV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACHV29.19%19.49%Net SellingNet Selling
EDIT44.12%33.76%Net SellingNet Selling
AVIR68.01%27.76%Net Selling
HUMA24.49%16.42%Net Selling
MDWD44.91%0.00%
View Top Biotech Stocks

Achieve Life Sciences Stock Ownership FAQ

Who owns Achieve Life Sciences?

Achieve Life Sciences (NASDAQ: ACHV) is owned by 29.19% institutional shareholders, 19.49% Achieve Life Sciences insiders, and 51.33% retail investors. Dialectic Capital Management LP is the largest individual Achieve Life Sciences shareholder, owning 3.55M shares representing 6.67% of the company. Dialectic Capital Management LP's Achieve Life Sciences shares are currently valued at $16.47M.

If you're new to stock investing, here's how to buy Achieve Life Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.